Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream

Introduction: Topical imiquimod is a safe and effective treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. The treatment is commonly associated with local inflammatory reactions, while systemic side effects are rare and generally mild. Only few cases of erythem...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilaria Salvi, Ilaria Trave, Riccardo Castelli, Aurora Parodi, Emanuele Cozzani
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4629
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540736007962624
author Ilaria Salvi
Ilaria Trave
Riccardo Castelli
Aurora Parodi
Emanuele Cozzani
author_facet Ilaria Salvi
Ilaria Trave
Riccardo Castelli
Aurora Parodi
Emanuele Cozzani
author_sort Ilaria Salvi
collection DOAJ
description Introduction: Topical imiquimod is a safe and effective treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. The treatment is commonly associated with local inflammatory reactions, while systemic side effects are rare and generally mild. Only few cases of erythema multiforme and Stevens-Johnson syndrome have been described in association with topical imiquimod application. Objective: We present a review of the existing cases of erythema multiforme and Stevens-Johnson syndrome reported in the literature, analyzing the clinical appearance, the histology and the treatment of the lesions. Method: Nine case of erythema multiforme were reported, characterized by cutaneous rash, bullae, crusting, erosive and targetoid lesions, mainly located at the extremities.  Mucosal involvement and systemic symptoms were sometimes present. Results: Three cases of Stevens-Johnson syndrome were associated with topical imiquimod. In all cases, the authors reported targetoid lesions and areas of erosion affecting trunk and limbs, associated with systemic symptoms, and, in 2 cases, to mucosal erosions. Conclusions: We hypothesize a possible role of interferon-γ, a cytokine involved in the pathogenesis of both herpes-associated erythema multiforme and Stevens-Johnson syndrome, which is released in response to the administration of imiquimod.
format Article
id doaj-art-f8084b536a71428fb8d3616cab110095
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-f8084b536a71428fb8d3616cab1100952025-02-04T15:41:40ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4629Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% CreamIlaria Salvi0https://orcid.org/0000-0003-0151-3126Ilaria Trave1https://orcid.org/0000-0002-5469-4517Riccardo Castelli2https://orcid.org/0000-0002-7184-7888Aurora Parodi3Emanuele Cozzani4Department of Dermatology, Dipartimento della Salute (DiSSal), University of Genoa; IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.Department of Dermatology, Dipartimento della Salute (DiSSal), University of Genoa; IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.Department of Dermatology, Dipartimento della Salute (DiSSal), University of Genoa; IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.Department of Dermatology, Dipartimento della Salute (DiSSal), University of Genoa; IRCCS, Ospedale Policlinico San Martino, Genoa, Italy.Department of Dermatology, Dipartimento della Salute (DiSSal), University of Genoa; IRCCS, Ospedale Policlinico San Martino, Genoa, Italy. Introduction: Topical imiquimod is a safe and effective treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. The treatment is commonly associated with local inflammatory reactions, while systemic side effects are rare and generally mild. Only few cases of erythema multiforme and Stevens-Johnson syndrome have been described in association with topical imiquimod application. Objective: We present a review of the existing cases of erythema multiforme and Stevens-Johnson syndrome reported in the literature, analyzing the clinical appearance, the histology and the treatment of the lesions. Method: Nine case of erythema multiforme were reported, characterized by cutaneous rash, bullae, crusting, erosive and targetoid lesions, mainly located at the extremities.  Mucosal involvement and systemic symptoms were sometimes present. Results: Three cases of Stevens-Johnson syndrome were associated with topical imiquimod. In all cases, the authors reported targetoid lesions and areas of erosion affecting trunk and limbs, associated with systemic symptoms, and, in 2 cases, to mucosal erosions. Conclusions: We hypothesize a possible role of interferon-γ, a cytokine involved in the pathogenesis of both herpes-associated erythema multiforme and Stevens-Johnson syndrome, which is released in response to the administration of imiquimod. https://dpcj.org/index.php/dpc/article/view/4629ImiquimodStevens-Johnson SyndromeErythema multiformeAdverse Drug Reactions
spellingShingle Ilaria Salvi
Ilaria Trave
Riccardo Castelli
Aurora Parodi
Emanuele Cozzani
Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
Dermatology Practical & Conceptual
Imiquimod
Stevens-Johnson Syndrome
Erythema multiforme
Adverse Drug Reactions
title Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
title_full Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
title_fullStr Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
title_full_unstemmed Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
title_short Stevens-Johnson Syndrome and Erythema Multiforme Induced by Imiquimod 5% Cream
title_sort stevens johnson syndrome and erythema multiforme induced by imiquimod 5 cream
topic Imiquimod
Stevens-Johnson Syndrome
Erythema multiforme
Adverse Drug Reactions
url https://dpcj.org/index.php/dpc/article/view/4629
work_keys_str_mv AT ilariasalvi stevensjohnsonsyndromeanderythemamultiformeinducedbyimiquimod5cream
AT ilariatrave stevensjohnsonsyndromeanderythemamultiformeinducedbyimiquimod5cream
AT riccardocastelli stevensjohnsonsyndromeanderythemamultiformeinducedbyimiquimod5cream
AT auroraparodi stevensjohnsonsyndromeanderythemamultiformeinducedbyimiquimod5cream
AT emanuelecozzani stevensjohnsonsyndromeanderythemamultiformeinducedbyimiquimod5cream